Company: GSHRW
Filing Date: 2025-08-14
Form Type: 10-Q
Source: 0001213900-25-075907
Chunk: 135

Company: Gesher Acquisition Corp. II
Filing Date: 2025-08-14
Form: 10-Q
Item: Part I, Item 4
Chunk 135
---
 Statement and (ii) 2025
Q1 Form 10-Q. Any of these factors could result in a significant or material adverse effect on our results of operations or financial
condition. Additional risks could arise that may also affect our ability to consummate an initial Business Combination. We may disclose
changes to such risk factors or disclose additional risk factors from time to time in our future filings with the SEC.

We may seek to extend the Combination Period,
which could reduce the amount held in our Trust Account and have adverse effects on our Company. 

If we are unable to consummate our initial Business
Combination on or before December 24, 2026, we may seek shareholder approval to extend the Combination Period by amending our Amended
and Restated Articles. In such event, our Public Shareholders will be provided the opportunity to have all or a portion of their Public
Shares redeemed. Any redemptions will reduce the amount held in our Trust Account, the effect of which may adversely affect our ability
to consummate our initial Business Combination and may also impair our ability to maintain our Nasdaq listing.

We anticipate that our securities will be
suspended from trading on Nasdaq and delisted if we do not consummate our initial Business Combination by March 14, 2028. Any trading
suspension or delisting could have a material adverse effect on the trading of our securities and may adversely affect our ability to
consummate an initial Business Combination.

Our IPO Registration Statement was declared effective
by the SEC on March 14, 2025 and our securities are currently listed on the Global Market tier of Nasdaq. Pursuant to our Amended and
Restated Articles, we have until December 24, 2026 to consummate our initial Business Combination.

Under the Nasdaq Rules, a SPAC’s Nasdaq-listed
securities will be immediately suspended from trading if the SPAC does not meet the Nasdaq 36-Month Requirement, and Nasdaq will, at such
point, commence delisting procedures. Although a SPAC can request a hearing before the hearing panel of Nasdaq (the “Hearing Panel”),
the scope of the Hearing Panel’s review is limited. If a SPAC completes a Business Combination after receiving a delisting determination
by the staff of the Listing Qualifications Department of Nasdaq (a “Staff Delisting Determination”) and/or demonstrates compliance
with all applicable initial listing requirements, the combined company can apply to list its securities on Nasdaq